Meeting
2014 ASCO Quality Care Symposium
Treatment patterns of patients with metastatic colorectal cancer in a large national U.S. claims-based data.
Authors
Yue Zhong
Tufts Medical Center, Boston, MA
Yue Zhong, Rajesh Kamalakar, Carl V Asche, Sibyl Anderson, Brian S. Seal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Science of Quality and Cost, Value, and Policy in Quality
Track
Science of Quality,Cost, Value, and Policy in Quality
Sub Track
Quality Measurement
Citation
J Clin Oncol 32, 2014 (suppl 30; abstr 268)
DOI
10.1200/jco.2014.32.30_suppl.268
Abstract #
268
Poster Bd #
F9
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Cost differential among systemic therapies for colon cancer.
First Author: Hasan Nadeem
Poster
2020 Gastrointestinal Cancers Symposium
Real-world data on treatment patterns of advanced CRC in third-line and beyond.
First Author: William A. Flood
Poster
2018 Gastrointestinal Cancers Symposium
Metastatic colorectal cancer (mCRC) treatment patterns in the Medicare population.
First Author: Jeremy Snider
Poster
2016 Gastrointestinal Cancers Symposium
A multinational, randomized, phase III trial of XELIRI (+bevacizumab) versus FOLFIRI (+bevacizumab) as the second-line chemotherapy for metastatic colorectal cancer: Asian XELIRI project (AXEPT).
First Author: Kei Muro